# Solifenacin

## Vesicare 5mg

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OVESI                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Indications        | Treatment of overactive bladder with symptoms of urge urinary incontinence， urinary frequency & urgency.                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | 5-10 mg once a day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Contraindications  | Urinary retention， gastric retention， uncontrolled narrow angle glaucoma.                                                                                                                                                                                                                                                                                                                                                                                                        |
| Adverse Effects    | Dry mouth， GI disturbances including constipation， blurred vision， dry eyes， urinary retention， lower limb edema， fatigue， cough. <Common> Gastrointestinal: Constipation (5.4% to 13.4% )， Xerostomia (10.9% to 27.6% ) <Serious> Cardiovascular: Prolonged QT interval Gastrointestinal: Bowel obstruction， Fecal impaction， Obstruction of colon Immunologic: Anaphylaxis Neurologic: Confusion， Headache， Somnolence Psychiatric: Hallucinations Other: Angioedema |
| Pregnancy          | No (limited) human data – animal data suggest moderate risk                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                      |

